Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
scPharmaceuticals Inc. develops innovative, patient-centric therapies for cardiorenal health, focusing on subcutaneous delivery of diuretics like FUROSCIX. Its products aim to reduce hospitalizations, lower healthcare costs, and improve outpatient care for heart failure and kidney disease patients. The company leverages proprietary formulations, drug-device combinations, and a specialized sales infrastructure to commercialize its FDA-approved and pipeline therapies globally.
This description was generated via AI from an annual report. Updated about 1 year ago.